KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bristol Myers Squibb (BMY) Non-Current Deffered Revenue (2016 - 2019)

Bristol Myers Squibb (BMY) has disclosed Non-Current Deffered Revenue for 11 consecutive years, with $448.0 million as the latest value for Q1 2019.

  • On a quarterly basis, Non-Current Deffered Revenue changed 0.22% to $448.0 million in Q1 2019 year-over-year; TTM through Mar 2019 was $448.0 million, a 0.22% change, with the full-year FY2018 number at $468.0 million, up 3.08% from a year prior.
  • Non-Current Deffered Revenue was $448.0 million for Q1 2019 at Bristol Myers Squibb, down from $468.0 million in the prior quarter.
  • In the past five years, Non-Current Deffered Revenue ranged from a high of $697.0 million in Q1 2015 to a low of $447.0 million in Q1 2018.
  • A 5-year average of $542.5 million and a median of $528.0 million in 2017 define the central range for Non-Current Deffered Revenue.
  • Peak YoY movement for Non-Current Deffered Revenue: tumbled 35.99% in 2015, then rose 3.08% in 2018.
  • Bristol Myers Squibb's Non-Current Deffered Revenue stood at $586.0 million in 2015, then fell by 6.66% to $547.0 million in 2016, then decreased by 17.0% to $454.0 million in 2017, then grew by 3.08% to $468.0 million in 2018, then decreased by 4.27% to $448.0 million in 2019.
  • Per Business Quant, the three most recent readings for BMY's Non-Current Deffered Revenue are $448.0 million (Q1 2019), $468.0 million (Q4 2018), and $486.0 million (Q3 2018).